About Aer Therapeutics
Aer Therapeutics is a company based in Raleigh (United States) founded in 2014 by John Fahy.. Aer Therapeutics has raised $41 million across 2 funding rounds from investors including Orbimed, Canaan and Hatteras Venture Partners. The company has 5 employees as of December 31, 2024. Aer Therapeutics offers products and services including AER-01. Aer Therapeutics operates in a competitive market with competitors including Savara Pharma, Icosavax, HilleVax, Precigen and Inimmune, among others.
- Headquarter Raleigh, United States
- Employees 5 as on 31 Dec, 2024
- Founders John Fahy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aer Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Series A
Jan 24, 2025
-
Investors
Orbimed
& 2 more
-
Employee Count
5
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aer Therapeutics
Aer Therapeutics offers a comprehensive portfolio of products and services, including AER-01. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Inhaled drug that liquifies mucus plugs for lung diseases
Unlock access to complete
Unlock access to complete
Funding Insights of Aer Therapeutics
Aer Therapeutics has successfully raised a total of $41M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.0M
-
First Round
First Round
(23 Dec 2022)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series A - Aer Therapeutics | Valuation |
investors |
|
| Dec, 2022 | Amount | Series A - Aer Therapeutics | Valuation | Canaan , Orbimed |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aer Therapeutics
Aer Therapeutics has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Orbimed, Canaan and Hatteras Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aer Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aer Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aer Therapeutics Comparisons
Competitors of Aer Therapeutics
Aer Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Savara Pharma, Icosavax, HilleVax, Precigen and Inimmune, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
|
|
| domain | founded_year | HQ Location |
Developer of computationally designed VLP vaccines for treating multiple infections
|
|
| domain | founded_year | HQ Location |
A norovirus vaccine is developed for infection prevention.
|
|
| domain | founded_year | HQ Location |
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases
|
|
| domain | founded_year | HQ Location |
Integrated clinical developmental services to treat food allergy, allergic rhinitis, and auto-immune disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aer Therapeutics
Frequently Asked Questions about Aer Therapeutics
When was Aer Therapeutics founded?
Aer Therapeutics was founded in 2014 and raised its 1st funding round 8 years after it was founded.
Where is Aer Therapeutics located?
Aer Therapeutics is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Who is the current CEO of Aer Therapeutics?
Jim Shaffer is the current CEO of Aer Therapeutics.
Is Aer Therapeutics a funded company?
Aer Therapeutics is a funded company, having raised a total of $41M across 2 funding rounds to date. The company's 1st funding round was a Series A of $36M, raised on Dec 23, 2022.
How many employees does Aer Therapeutics have?
As of Dec 31, 2024, the latest employee count at Aer Therapeutics is 5.
What does Aer Therapeutics do?
Aer Therapeutics was founded in 2014 and is headquartered in Raleigh, United States. Focus is placed on biotechnology within the respiratory sector, where an inhaled treatment approach is developed for lung diseases involving excess mucus and plugs. AER-01, a thiol-modified carbohydrate, is utilized to cleave mucin disulfide bridges, thereby liquefying mucus in muco-obstructive conditions. Operations center on advancing this therapy for clinical application.
Who are the top competitors of Aer Therapeutics?
Aer Therapeutics's top competitors include Savara Pharma, HilleVax and Icosavax.
What products or services does Aer Therapeutics offer?
Aer Therapeutics offers AER-01.
Who are Aer Therapeutics's investors?
Aer Therapeutics has 3 investors. Key investors include Orbimed, Canaan, and Hatteras Venture Partners.